Analgesics in Kazakhstan demonstrates outstanding performance in 2026, with value growth expected to expand by 15% to KZT47.2 billion. This environment is characterised by robust demand for branded, fast-acting, and convenient solutions, driven by a growing and ageing population, rising incomes, and a strong consumer inclination towards both premium and affordable pain relief. The landscape remains highly competitive and fragmented, creating an attractive scenario for both established and emerging players. To capitalise on these dynamics, brands should to prioritise trusted efficacy, optimise portfolios towards high-turnover products, expand pharmacy and online distribution, and balance premiumisation with affordability, especially in paediatric formats. As digital channels expand and consumer preferences evolve, successful strategies will hinge on product accessibility, transparent pricing, and targeted innovation in delivery formats rather than novel active ingredients.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Kazakhstan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Kazakhstan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Kazakhstan report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Kazakhstan?
- Which are the leading brands in Analgesics in Kazakhstan?
- How are products distributed in Analgesics in Kazakhstan?
- How has the regulatory and operating environment for Analgesics changed in Kazakhstan?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Rising prices and fast-acting branded products reshape analgesics
Systemic analgesics dominate as portfolio simplification concentrates demand on proven brands
Ketonal gel and affordable paracetamol reshape consumer behaviour through trust and price
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Systemic analgesics will dominate growth while topical formats expand on targeted relief innovation
Manufacturers expand premium portfolios as consumers seek convenience
Population growth and rising incomes underpin premium product uptake
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Trusted efficacy and broad accessibility sustain leading brands amid competitive pressure
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain leadership as e-commerce gains traction
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!